ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 577

The Value of C-Reactive Protein As a Predictor of Radiographic Spinal Progression Is Strongly Dependent on β-Fibrinogen and Factor XIII a-Subunit Genotypes in Patients with Axial Spondyloarthritis

Denis Poddubnyy1,2, Christian Schwedler2, Hildrun Haibel2, Martin Rudwaleit2,3, Joachim Sieper2 and Berthold Hoppe4, 1German Rheumatism Research Centre, Berlin, Germany, 2Charité Universitätsmedizin Berlin, Berlin, Germany, 3Klinikum Bielefeld Rosenhöhe, Bielefeld, Germany, 4Unfallkrankenhaus Berlin, Berlin, Germany

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Ankylosing spondylitis (AS), spondylarthritis and spondylarthropathy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Spondyloarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

It has been shown in the past that inflammatory activity (i.e., elevated C-reactive protein) predicts radiographic spinal progression in patients with axial spondyloarthritis (axSpA). Fibrinogen and factor 13 genotypes have been recently identified as factors modifying inflammatory response due to differences in the properties of the fibrin network related to particular genotype constellations [1].

The objective of the current study was to investigate the association between α-fibrinogen (FGA), β-fibrinogen (FGB) and factor XIII A-subunit (F13A) genotypes with the level of CRP and radiographic spinal progression over 2 years in patients with early (up to 10 years symptom duration) axial SpA.

Methods:

Altogether 207 patients with early axial SpA from the German Spondyloarthritis Inception Cohort (GESPIC) were included. Clinical data and CRP level were collected at baseline and every 6 months thereafter. A time-averaged CRP level over 2 years (up to 5 time-points) was calculated. Structural damage in the spine was assessed on spinal radiographs at baseline and after two years according to the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS). Significant radiographic spinal progression was defined as the worsening of the mSASSS by ≥2 points over two years. FGB −455G>A (rs1800790), FGA T312A (rs6050) and F13A V34L (rs5985) genotypes were determined with available samples using allele-specific primer pairs.

Results:

No clear association between studied genotypes and the time-averaged CRP or radiographic spinal progression could be found. However, the effect of CRP in the predictive model for radiographic spinal progression was strongly dependent on FGB genotype (table): the odds ratio (OR) for the elevated time-averaged CRP as a predictor of the mSASSS worsening by ≥2 points over two years was 5.47 (95%CI 1.51-19.79) in FGB −455GG (wild-type) carriers, while there was no such effect of CRP in carriers of the alternative (A) allele, OR=0.99 (95%CI 0.20-4.92). Interestingly, this effect modification was dependent also on F13A genotype: in carriers of the wild-type genotypes of both FGB (−455GG) and F13A (34VV), n=65, the OR for the elevated CRP as a predictor of radiographic spinal progression was 10.8 (95%CI 1.07-108.0), while alternative allele carriers (F13A 34L) showed a weak and non-significant association of CRP with radiographic spinal progression even in the presence of the wild-type FGB genotype (n=59): OR=2.01 (95%CI 0.34-12.04). F13A itself as well as FGA genotypes showed no effect-modifying effects on CRP.

Conclusion:

The predictive value of CRP regarding radiographic spinal progression seems to be dependent on FGB and F13A genotypes. This might also suggest  that CRP is not a good indicator of inflammation in individuals with a specific genetic background.

 

References:

1. Hoppe B, et al. Ann Rheum Dis. 2012 Jul; 71(7):1163-1169.


Disclosure: D. Poddubnyy, None; C. Schwedler, None; H. Haibel, None; M. Rudwaleit, None; J. Sieper, None; B. Hoppe, None.

To cite this abstract in AMA style:

Poddubnyy D, Schwedler C, Haibel H, Rudwaleit M, Sieper J, Hoppe B. The Value of C-Reactive Protein As a Predictor of Radiographic Spinal Progression Is Strongly Dependent on β-Fibrinogen and Factor XIII a-Subunit Genotypes in Patients with Axial Spondyloarthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/the-value-of-c-reactive-protein-as-a-predictor-of-radiographic-spinal-progression-is-strongly-dependent-on-%ce%b2-fibrinogen-and-factor-xiii-a-subunit-genotypes-in-patients-with-axial-spondyloarthriti/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-value-of-c-reactive-protein-as-a-predictor-of-radiographic-spinal-progression-is-strongly-dependent-on-%ce%b2-fibrinogen-and-factor-xiii-a-subunit-genotypes-in-patients-with-axial-spondyloarthriti/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology